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Flavobacterium columnare is a bacterial pathogen causing high mortality rates for many freshwater ﬁsh species. Fish vaccination
with a safe and eﬀective vaccine is a potential approach for prevention and control of ﬁsh disease. Here, in order to produce
bacterial ghost vaccine, a speciﬁc Flavobacterium lysis plasmid pBV-E-cat was constructed by cloning PhiX174 lysis gene E and
the cat gene with the promoter of F. columnare into the prokaryotic expression vector pBV220. The plasmid was successfully
electroporated into the strain F. columnare G4cpN22 after curing of its endogenous plasmid. F. columnare G4cpN22 ghosts
(FCGs) were generated for the ﬁrst time by gene E-mediated lysis, and the vaccine potential of FCG was investigated in grass carp
(Ctenopharyngodon idellus) by intraperitoneal route. Fish immunized with FCG showed signiﬁcantly higher serum agglutination
titers and bactericidal activity than ﬁsh immunized with FKC or PBS. Most importantly, after challenge with the parent strain G4,
the relative percent survival (RPS) of ﬁsh in FCG group (70.9%) was signiﬁcantly higher than FKC group (41.9%). These results
showed that FCG could confer immune protection against F. columnare infection. As a nonliving whole cell envelope preparation,
FCG may provide an ideal alternative to pathogen-based vaccines against columnaris in aquaculture.
1.Introduction
Flavobacterium columnare, a Gram-negative-gliding bac-
terium, is the causative agent of columnaris disease, one
of the most important bacterial diseases of freshwater ﬁsh
species [1]. This bacterium is ubiquitous in aquatic environ-
ments, aﬀecting wild and cultured ﬁsh as well as ornamental
ﬁsh in aquaria [2]. The onset of columnaris disease is
characterized by external infections in the ﬁsh body surface,
gills, or ﬁns. The disease often ends in death, leading to large
economic losses in the ﬁsh farming industry.
In recent years, control of ﬁsh diseases using chemother-
apy results in emergence of antibiotic-resistant microbes
and negative impacts on environment and human beings
[3–6]. Therefore, vaccination has become an increasingly
important prevention strategy against infectious agents in
farmed ﬁshes [7] .S e v e r a la t t e m p t sh a v eb e e nm a d et o
induce protection against columnaris disease with formalin-
or heat-inactivated preparations of F. columnare,y e tn o
protection or only partial protection was achieved following
immersion or injection immunization [8–10]. Currently, a
modiﬁed live columnaris vaccine has been developed and
commercialized in the United States [11], and it is eﬃcacious
for prevention of columnaris disease in channel catﬁsh and
largemouthbassfry[12,13]. However, live vaccines may bear
the danger of reversion.
Bacterial ghosts have been given increasing attention as
a promising new approach in nonliving vaccine technology.
The potential usefulness of the technology has been reported
in a wide variety of mammalian pathogenic Gram-negative
bacteria[14–16]andinaﬁshpathogenicbacterium,Edward-
siella tarda [17, 18]. Generally, Bacterial ghosts are produced
by the controlled expression of bacteriophage PhiX174 lysis
gene E, and the E protein leads to the formation of small2 Journal of Biomedicine and Biotechnology
transmembrane pores through which cytoplasmic contents
are expelled [14–19]. The resultant bacterial ghosts retain
the functional and antigenic determinants of the envelope
with their living counterparts; therefore they possess good
immunogenicity and bioadhesive properties and are able to
induce eﬀective immunoprotection [20, 21].
In this study, F. columnare ghosts have been generated
for the ﬁrst time by gene E-mediated lysis, and immune
protection against infection of F. columnare was detected
in Grass carp (Ctenopharyngodon idellus) by intraperitoneal
immunization with the ghosts.
2.MaterialsandMethods
2.1. Bacterial Strains, Culture Conditions, and Plasmids. The
highly virulent pathogenic strain Flavobacterium columnare
G4, isolated from a severe natural outbreak of gill rot disease
in cultured cyprinid ﬁshes, was kindly provided by Institute
of Hydrobiology, Chinese Academy of Sciences. The strain
was identiﬁed by biochemical diagnostic methods [22]a n d
species-speciﬁc PCR [23]. It is resistant to ampicillin and
tobramycin but highly sensitive to chloramphenicol. Shieh
broth [24] was used as the basic culture medium for F.
columnare G4 which was grown at 26◦C and supplemented
withtobramycin(Sigma,USA)ataconcentrationof1μg/mL
when needed. E. coli DH5α kept in this laboratory was cul-
turedinLuria-Bertanimedium. Incubationtemperaturesfor
repression and expression of the lysis gene in transformants
were 26◦Ca n d4 2 ◦C, respectively.
The plasmid pBV220 was a kind gift from Professor
Hui Wang of Academy of Military Medical Sciences, Bei-
jing, China. It is a prokaryotic nonfusion expression vector
with an ampicillin resistance gene and a λpL/pR-cI857
temperature-sensitive system that can express target gene
inserted in multiple cloning sites (MCS) at 42◦C. The plas-
mid pLysS with a chloramphenicol resistant gene (cat gene)
was extracted from the strain E. coli BL21 (DE3)-pLysS
(TransGen Biotech, Beijing, China) using the GeneJET
Plasmid Maxiprep Kit (Fermentas, Canada). Bacteriophage
PhiX174 RF1 DNA was purchased from Fermentas.
2.2. Construction of Gene E-Mediated Lysis Vector with
Cat Gene. The lysis gene E was ampliﬁed by PCR from
PhiX174 RF1 DNA with oligonucleotide primers E-F (5 -
ATCAGAATTCATGGTACGCTGGACTTTGTG-3 )a n dE -
R( 5  -GCCTGCTGCAGTACATCACTCCTTC-3 ) contain-
ing the EcoRI and PstI restriction enzyme sites (underlined),
respectively. The ampliﬁcations were performed for 1 cycle
of 5min at 94◦C, 28 cycles of 45s at 94◦C, 45s at 56◦C,
1minat72 ◦C, with a ﬁnal extension step at 72◦C for 10min.
PCR products were visualized on 1% trisacetate agarose gels
stained with ethidium bromide, puriﬁed with GeneJET Gel
Extraction Kit (Fermentas), cloned into pMD-18T vector
(TaKaRa, Dalian, China) via T/A cloning, and designated
as pT-E. The gene E was excised from the pT-E plasmid by
EcoRI and PstI (Fermentas) digestion and then inserted into
the plasmid pBV220 which was predigested with the same
enzymes. The resulting plasmid was designated as pBV-E.
The cat gene was ampliﬁed from the plasmid pLysS with
primers Cat-F (5 -GCCGATATCATGGAGAAAAAAATC-3 ,
EcoRV site underlined) and Cat-R (5 - TTATCATTACGC-
CCCGCCCTGCCA-3 ) in a standard PCR protocol. The
cat gene (675 bps) was puriﬁed and cloned into pMD-18T
via T/A cloning, as pT-cat. A regulating sequence includ-
ing promoter was ampliﬁed from the genomic DNA of
F. columnare G4 with the Pfu DNA polymerase (Fermentas)
which produces blunt ended PCR products and primers
Catpro-F (5 -GATAGAATAGAAAAAAGAAAATGTA-3 )
and Catpro-R (5 -GGCGATTTGCCTTTTTTATAAAAT-
3 ). The primers were designed according to the upstream
sequence of acetyl-coenzyme, a synthetase gene of F. colum-
nare in Genbank (AY387595.2). The DNA fragment includ-
ing promoter (167bps) was subcloned into pT-cat which
had been digested with EcoRV, as pT-pro-cat. The sequence
including the promoter and cat gene was ampliﬁed from
pT-pro-cat with the Pfu DNA polymerase and the primers
Catpro-F and Cat-R and ligated into pBV-E which was
predigested with ScaI. The resulting plasmid was designated
as pBV-E-cat (Figure 1).
2.3. Curing of an Endogenous Plasmid from F. columnare G4.
F. columnare G4 was cured of its endogenous plasmid by use
of the intercalating dye acridine orange (AO, Sigma, USA).
Basically, the ﬁlter-sterilized AO was added into the logarith-
mically growing culture (Tobramycin 1μg/mL, OD600 = 0.4)
of F. columnare G4 at concentrations ranging from 25μg/mL
to 450μg/mL in 18 groups. The culture was incubated at
the optimum growth temperature 26◦C for 26h. Then the
culture containing the highest concentration of AO which
still allows growth was used as a source of inoculum for
plating cells on Shieh agar plate at 26◦C until colony growth.
Individual colonies were detected by plasmid puriﬁcation
and identiﬁed by primer-speciﬁc PCR with primers Fcp510-
F( 5  -GTGACGGTGACGATAAGT-3 ), Fcp510-R (5 -CCT-
TCTTGCTGGTTCTGT-3 ), Fcp1152-F (5 -GGTTCGGCG-
TTCTATGG-3 ), and Fcp1152-R (5 -GGTGGTGAGTCG-
TTATACAA-3 ) according to the sequence of the plasmid
(Another study processing). After large-scale screening, 28
strains which have stably lost the endogenous plasmid were
obtained and designated as F. columnare G4cpN1-N28.
2.4.ElectroporationofF.columnareG4cpN1-N28andGenera-
tion of F. columnare G4cpN22 Ghosts. The above strains were
inoculated into 100mL Shieh broth and grown at 26◦Ct o
an OD600 of 0.3 with agitation of 150rpm. The cells were
washed in ice-cold sucrose electroporation buﬀer (137mM
sucrose, 1mM Hepes, 10% (v/v) glycerol, pH 8.0) and then
suspended in ice-cold sucrose buﬀer at 1/100 of the original
volume. The lysis plasmid pBV-E-cat DNA (3-4μg) was
mixedwith100μLofthecellsuspension,transferredtoapre-
cooling1mmcuvetteandelectroporatedusingaGenePulser
(Bio-Rad, CA, USA) and Pulse controller (1.5kV, 25μF,
200Ω) producing a time constant of ±4.0ms. Immediately
after electroporation, 800μL of Shieh medium was added



















Figure 1: Physical map of the lysis plasmid pBV E cat. Gene E, under transcriptional control of the temperature-sensitive repressor;
rrBT1T2: ribosome rrnB gene providing translation stop signal terminator sequence; pro: the regulating sequence including promoter; cat:
chloramphenicol acetyl transferase gene; ori: replication origin; cIts857: restraining gene of lambda bacteriophage adapted to heat induced
expression.
cells were plated onto Shieh agar plates containing 10μg/mL
chloramphenicol and grown at 26◦C for 24–36h.
F. columnare G4cpN22 was the only one strain which had
the ability to accept and maintain the pBV-E-cat. When the
cultures reached an OD600 of 0.3 at 26◦C, the expression of
the gene E was induced by a temperature upshift to 42◦C
immediately. The number of cells was determined using a
6 × 6 drop plate method [25] before induction, with the
exception that Shieh agar plates were used and incubated at
26◦Cf o r3 6 h .A td i ﬀerent time points after induction, an
optical density was measured until no further decrease was
detected, and viable cell counts were determined by plating
serial dilutions on Shieh agar plates. At the end of the lysis
process,100μLofcultureswasinoculatedonShiehagarplate
in order to examine whether or not there were any surviving
cells. Eﬃciency of ghost induction was expressed by lysis rate
whichwascalculatedusingthefollowingformula:lysisrate =
(1 −CFUoflysiscompleted/CFUbeforeinduction) ×100%.
Finally, the harvested F. columnare G4cpN22 ghosts (FCGs)
were washed twice with ice-cold phosphate-buﬀered saline
(PBS, pH 7.3), lyophilized, and stored at 4◦C until further
use. The lyophilized FCG preparations were reconstituted
with PBS to a bacterial concentration of 1 × 108 cells/mL
prior to immunization.
2.5. Scanning Electron Microscopy (SEM) and Transmission
Electron Microscopy (TEM). The FCGs for SEM (S-500,
Hitachi, Japan) were ﬁxed with 2.5% glutaraldehyde in
0.01M PBS (pH 7.0) at 4◦C for 2h. Cells were rinsed 3 times
with the same buﬀer and postﬁxed in 1% osmium tetroxide
for 1.5h at 4◦C. Subsequently, the cells were dehydrated
with a graded series of ethyl alcohol and isoamyl acetate.
Following ﬁnal dehydration, cells were dried with liquid
carbon dioxide and sputtered with platinum tetroxide using
a pure platinum coater before scanning.
Ghost preparations for TEM (H-800, Hitachi) were
obtained the same way, except that ﬁxation was done for
3h. Then the samples were washed as above and ﬁxed with
2% osmic acid for 2h, followed by washing three times with
0.1M PBS before microscopy.
2.6. Experimental Fish Immunization and Challenge Test
2.6.1. Fish and Rearing Conditions. Healthy grass carps
weighing 45 ± 5g were obtained from Freshwater Fishery
Research Institute of Shandong Province, China. Prior to
vaccination, ﬁsh were acclimated for at least two weeks in
400L aquarium supplied with speciﬁc pathogen-free aerated
fresh water treated with ultraviolet light. Light cycle was held
constant at 12hlight/12hdark per day and water temper-
ature was maintained at 24 ± 2◦C. Fish were fed with a
commercialpelleteddietat2%bodyweightperdaythrough-
out the study. Fish were anaesthetized by immersion into
90mg/L tricaine methanesulfonate (MS-222, Sigma, USA)
prior to experiments involving injection, blood collection, or
sacriﬁce. Before each of the infection and vaccination exper-
iments, ﬁsh were randomly sampled for the examination
of bacterial recovery from blood, liver, and spleen, and no
bacteria could be detected in all the ﬁsh examined.
2.6.2. Generation of Formalin-Killed F. columnare. F. colum-
nare G4 was inoculated into Shieh broth and incubated
at 26◦C for 24h. For formalin-killed F. columnare (FKC)
preparation, formalin was added to the culture at a ﬁnal
concentration of 0.3%. After a 24h incubation at 26◦C,
bacteria were washed three times with PBS and resuspended4 Journal of Biomedicine and Biotechnology
in PBS to a bacterial concentration of 1 × 108 cells/mL. A
viability test of 1% of the resulting volume was conducted on
Shieh solid medium and determined to be culture negative.
FKC preparation was frozen at −20◦C until use.
2.6.3. Injection Immunization. Grass carp were divided ran-
domly into three treatment groups, each group with one
hundred and sixty ﬁsh. Fish in two vaccinated groups were
injected intraperitoneally (ip) with 100μLo fF C Go rF K Ca t
1 × 107 cells/ﬁsh using 27-gauge needles. Fish in the control
group were injected ip with 100μL of PBS as a mock immu-
nization. At 4 weeks postprimary immunization, identical
booster immunizations were administered in the vaccinated
groups and ﬁsh in the control group were injected ip with
100μL of PBS. Before vaccination, blood was collected by
caudal venipuncture and pooled from a random sample of
ten ﬁsh per group to conﬁrm that the ﬁsh were free from F.
columnare antibody.
2.6.4. Serum Agglutination Reaction and Bactericidal Activity
Assay. At each time point of postimmunization, serum was
collected from 30 randomly selected ﬁsh (ten pools of 3 ﬁsh)
in each group. Serum agglutination reaction was applied to
reﬂect the titres of anti-F. columnare antibody produced by
grasscarp[26].F. columnare G4wasincubatedinShiehbroth
to midlogarithmic phase and resuspended in PBS. Serial
twofold dilution of test serum in PBS and equal volume of F.
columnare G4 suspension was added to each well of 96-well
microtitre plates. Doubling dilutions of positive and negative
sera were included on every plate as controls. The plates were
coveredandincubatedinhumidiﬁedairat25◦Cfor18h.The
highest serum dilution that showed a circular diﬀuse button
with fuzzy edges at the bottom of the well was considered
a positive reaction, and a circular compact cell button was
considered to be a negative reaction. Serum endpoint titre
was deﬁned as the reciprocal of the highest dilution.
Serum bactericidal activity analysis was performed as
described [27]. Brieﬂy, Two microliters of F. columnare G4
suspension were mixed with 20μL of serum, and the mixture
was incubated at 26◦C for 1h, followed by plating on Shieh
agar plates supplemented with tobramycin and incubating at
26◦C for 48h. In the bacterial control group, the serum was
replaced by PBS. The number of colonies on the plates was
counted and veriﬁed to be F. columnare by speciﬁc PCR [23].
Bactericidal rate was calculated as follows: (1 − the number
ofviablebacteriaafterserumtreatment/thenumberofviable
bacteria after PBS treatment) × 100%.
2.6.5. Challenge Infection and Immune Protection. Before
challenge, all ﬁsh were clinically healthy, and there was no
evidence of F. columnare infection. A random sample of 120
ﬁsh was selected from each group (control group and both
vaccinated groups) and divided into three replicate of 40 ﬁsh
at time of challenge. The ﬁsh were challenged at day 50 post-
primaryimmunization,viaipinjectionwithF. columnare G4
at 2 × 106 cells/ﬁsh (5 × LD50 based on preliminary work).
Mortality was monitored twice daily for 14 days following
challenge, and the cumulative percent mortality (CPM) was
calculatedforeachtreatmentgroup.Relativepercentsurvival
(RPS) was determined as previously described [28], RPS =
(1 −immunizedgroupmortality/controlgroupmortality) ×
100. Dead or moribund ﬁsh exhibited gross pathological
changes, and routine bacteriological examination was per-
formed on freshly dead ﬁsh.
2.7. Statistical Analysis. All data were presented as mean ±
SD. Statistical analyses were performed using SPSS 15.0 soft-
ware (SPSS Inc., Chicago, IL, USA). Serum agglutination
titres and bactericidal activities were analyzed by two-way
ANOVA followed by pairwise comparisons (Tukey’s test).
Challenge test data were analyzed by Chi-square test. Diﬀer-
ences were considered signiﬁcant at P<0.05.
3. Results
3.1. Generation and Characterization of F. columnare
G4cpN22 Ghost. Since F. columnare G4cpN22 was high
sensitive to chloramphenicol, but not to ampicillin, a speciﬁc
lysis vector with the cat gene had to be constructed
(Figure 1). The lysis plasmid pBV E cat was successfully
electroporated into F. columnare G4cpN22 which growth
characteristics were similar to F. columnare G4. Generation
of F. columnare ghosts (FCGs) was performed by shifting the
incubation temperature to 42◦C to inactivate the repressor
protein and activate lysis gene E. Onset of the lysis occurred
1haftertemperatureelevationbecausethenumbersofviable
cells began to decrease at 1h after induction, and the lysis
process was completed 10h after induction (Figure 2). The
results of three replicate experiments showed the eﬃciency
of FCGs induction was 99.99% at the end of the lysis
process. The lyophilized FCGs were analyzed for survivors
by inoculating 100mL of growth media with a tenfold
immunization dose at 26◦C, but no bacterial growth was
detected. The lyophilized FCG preparation was used for
vaccination studies in ﬁsh.
Electron microscopic analysis of FCG revealed no gross
alterations in cellular morphology compared to unlysed cells
(Figures 3(a) and 3(b)) except for the lysis pore (arrow,
Figure 3(a)). Pores ranging from 100 to 300nm in diameter
were observed in FCG by scanning electron microscopy. The
structural integrity and the loss of cytoplasmic materials
were observed in FCG by transmission electron microscopy
(Figure 3(b)).
3.2. Serum Agglutination Reaction and Bactericidal Activity
Assay. The agglutination reaction against F. columnare G4
was detected in grass carp immunized ip with bacterial
ghosts, formalin-killed cells, or PBS. Fish immunized with
FCG or FKC showed signiﬁcantly higher agglutination
titer than control ﬁsh in which no agglutination reaction
was detected, while ﬁsh immunized with FCG showed
signiﬁcantly higher titers than ﬁsh immunized with FKC at
all the examined time points (P<0.01) (Figure 4). The
agglutination reaction in FCG group initially peaked at 2
weeks postprimary immunization, subsided by week 4 and
then more than doubled (mean geometric titre 478) 2 weeksJournal of Biomedicine and Biotechnology 5
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Figure 2: Growth and lysis kinetics of F. columnare G4cpN22
harboring plasmid pBV E cat by temperature induction of gene E
expression. At time zero, the growth temperature of three bottles of
thecultureswasshiftedfrom26◦Cto42 ◦C(ﬁlledsymbols),whereas
the others served as noninduced control at 26◦C (open symbols).
Growth and lysis were monitored by the measurement of the OD600
(opencirclesandﬁlledcircles)andthedeterminationofthenumber
of CFU (open squares and ﬁlled squares and discontinuous lines).
after booster immunization (6 weeks). The high titer of FCG
group was 3.5-fold higher than FKC group and persisted
longer than FKC group.
Serum bactericidal activity was the lowest in PBS group
and the highest in FCG group. Serum bactericidal activity of
FCG group was elevated signiﬁcantly above FKC group and
PBS control group at all times postimmunization (P<0.01)
(Figure 5). The viable bacterial counts (41%) were closely 2-
fold lower in FCG group compared with FKC group (80%)
at 2 weeks after booster immunization (6 weeks).
3.3. Induction of Protective Immunity following Immunization
with FCG Vaccine. A protective immune response against
virulent F. columnare G 4w a sc o n f e r r e dt og r a s sc a r pf o l -
lowing immunization by ip injection with FCG preparation
(Table 1). Fish given mock immunizations with PBS sus-
tained high CPM (nearly 100%) upon challenge with the
F. columnare G4 strain, while ﬁsh immunized with FCG or
FKCexhibitedasigniﬁcantlydecreasedCPMat7weekspost-
primary immunization (P<0.05). The RPS of FCG group
was 70.9%, signiﬁcantly higher than the RPS of FKC group
(41.9%). Challenge mortalities exhibited typical signs of F.
columnareinfection.Bacteriawithphenotypiccharacteristics
of F. columnare G4 were recovered from all dead ﬁsh.
4. Discussion
Bacterial ghosts represent a potential new concept in geneti-
cally inactivated vaccines. In the present study, F. columnare
ghosts were generated for the ﬁrst time by the controlled
expression of the lysis gene E.G e n eE-mediated lysis of
bacteria resulting in empty cell envelopes is suggested as an
alternative approach for the inactivation of bacteria without
chemical or physical stress, which have frequently caused the
reduction of antigenicity [8–10]. Since the outer membrane
proteins (OMPs) of pathogenic bacteria play important
roles in protective antigenicity [29–31], the minimized
conformational changes of OMPs in bacterial ghosts would
provide a promising avenue for enhancing vaccine eﬃcacy.
However, the lysis process of F. columnare G4cpN22
harboring plasmid pBV-E-cat was slower than many other
Gram-negative bacteria such as E. coli, Salmonella enteritidis,
and Vibrio cholerae, in which lysis was completed 2–4h
after lysis induction [32, 33]. Previous studies proved that
the promoters which drive gene expression in other gram-
negative bacteria generally do not function well in the
Bacteroidetes including Flavobacterium species [34, 35]. It
was speculated that the slower lysis behavior observed in F.
columnare might result from reduced power of the lambda
PR/PL promoter in F. columnare, reduced susceptibility of
the F. columnare cell wall to the E protein, or lower copy
of plasmid pBV-E-cat in F. columnare. Further study to
quantify the gene E expression during lysis induction would
be valuable to ﬁnd the factor responsible for the weakened
lysis kinetics.
The immune response and protection induced after
immunization of grass carp with FCG vaccine were ﬁrst
tested. It was found that ﬁsh immunized with FCG through
ip injection showed signiﬁcantly higher serum agglutination
titers and serum bactericidal activity than ﬁsh immunized
with FKC, which indicated that FCG was more favorable
to induce speciﬁc humoral immune responses. An elevated
level of protection in FCG vaccinated ﬁsh to the ip injec-
tion challenge was also observed, which is consistent with
previous ﬁndings [18, 36]. The low level of response to
FKC preparations could be related to the inactivation of
major immunogenic proteins. Bader et al. [9]r e p o r t e d
that formalin inactivation resulted in masking of at least
one potentially important F. columnare antigen in channel
catﬁsh. The eﬀect of formalin on the antigenic properties
of F. columnare was partially addressed here by killing the
bacteria with a low formalin concentration (0.3%) and
washing three times in PBS. Nevertheless, the protein cross-
linking properties of formalin may have resulted in reduced
antigenicity. Compared to formalin-killed bacterial vaccines,
the adjuvant eﬀect of ghost bacterial vaccines has been
reported in many pathogenic bacteria [20]. Bacterial ghosts
carry immunostimulatory compounds that have adjuvant
properties, such as lipopolysaccharides (LPS), lipids, pepti-
doglycan, or ﬂagella. These intrinsic adjuvant properties of
bacterial ghosts were shown to activate the innate immune
system as well as the acquired immune response [37,
38]. Moreover, some reports showed eﬀective induction of
cell-mediated immunity, which would play a key role in
protection against intracellular pathogens, by bacterial ghost
vaccines [39–41].
In conclusion, FCGs have been shown to induce stronger
protective immunity than FKC in grass carp. Given its6 Journal of Biomedicine and Biotechnology
(a) (b)
Figure 3: Electron microscopy analyses of F. columnare G4cpN22 ghosts. (a) Arrow showed the transmembrane lysis tunnel located mainly
at the cell poles via SEM. (b) Loss of cytoplasmic materials of F. columnare G4cpN22 ghosts was shown by TEM. The lysed cells showed
uneven and low electron density and retained the basic cell morphology of the bacterial cells, while the unlysed cells showed even and high
electron density in an integral cell structure.
Table 1: Cumulative percent mortality (CPM) and relative percent survival (RPS) of grass carp following F. columnare G4 strain challenge
at 50days after primary immunization.
group Number of ﬁsh challenged Mean CPM ±SD (%) RPS (%)
FCG 120 28.3 ±5.0a 70.9
FKC 120 56.7 ±8.0b 41.9
PBS 120 97.5 ±2.5c








































Weeks after primary immunization
Figure 4: Serum agglutination titres of ﬁsh vaccinated with FCG
and FKC at diﬀerent time points postprimary immunization. Grass
carp were vaccinated with FCG or FKC via intraperitoneal injection
with a boost at 4 weeks after primary immunization. Serum
agglutination titres represent the highest dilutions that gave rise to
positive reaction. The titres of FCG group were signiﬁcantly higher






































Weeks after primary immunization
Figure 5:Serumbactericidalactivitiesofgrasscarpvaccinatedwith
FCG or FKC. The grass carp were vaccinated with FCG or FKC
via intraperitoneal injection with a boost at 4 weeks after primary
immunization. Serum bactericidal activities of FCG group were
signiﬁcantly higher than FKC group at the examined time points
of postimmunization (P<0.01).Journal of Biomedicine and Biotechnology 7
safety and high level of immunoprotective eﬃcacy, FCG
may provide an ideal alternative to pathogen-based vaccines
against columnaris in aquaculture.
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